PNC Financial Services Group’s Aprea Therapeutics APRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,000
| Closed | -$4.07K | – | 4781 |
|
|
2024
Q2 | $4.07K | Hold |
1,000
| – | – | ﹤0.01% | 4052 |
|
|
2024
Q1 | $6.69K | Hold |
1,000
| – | – | ﹤0.01% | 3875 |
|
|
2023
Q4 | $4.7K | Hold |
1,000
| – | – | ﹤0.01% | 3957 |
|
|
2023
Q3 | $4.17K | Hold |
1,000
| – | – | ﹤0.01% | 4038 |
|
|
2023
Q2 | $3.15K | Hold |
1,000
| – | – | ﹤0.01% | 4239 |
|
|
2023
Q1 | $4.44K | Hold |
1,000
| – | – | ﹤0.01% | 4076 |
|
|
2022
Q4 | $6.62K | Hold |
1,000
| – | – | ﹤0.01% | 3901 |
|
|
2022
Q3 | $13K | Hold |
1,000
| – | – | ﹤0.01% | 3633 |
|
|
2022
Q2 | $15K | Buy |
+1,000
| New | +$15K | ﹤0.01% | 3614 |
|
|
2020
Q4 | – | Sell |
-100
| Closed | -$48K | – | 3955 |
|
|
2020
Q3 | $48K | Hold |
100
| – | – | ﹤0.01% | 2758 |
|
|
2020
Q2 | $78K | Buy |
+100
| New | +$78K | ﹤0.01% | 2479 |
|